Fat patch

A fat-burning skin patch has been tested on obese mice at Columbia University Medical Center. The patch contains a pharmaceutical that converts white, subcutaneous, fat, into brown adipose tissue and so could be used not only to remedy local fat deposits for cosmetic purposes without surgery but could also boost metabolism and perhaps treat obesity and metabolic disorders should it prove viable in people. The drug, rosiglitazone (Avandia) or CL316243, a beta adrenergic agonist, led to a 20 percent reduction in fat on treated sites in the laboratory mice.